Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experience

Quintino Giorgio D'Alessandris, Nicola Montano, T Cenci, Maurizio Martini, Liverana Lauretti, F Bianchi, Luigi Maria Larocca, G Maira, E Fernandez, Roberto Pallini

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

13 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experience'. Insieme formano una fingerprint unica.

Pharmacology, Toxicology and Pharmaceutical Science